Multiplex Detection Compositions, Methods, and Kits

• US 20110223596A1
• Filed: 02/18/2011
• Published: 09/15/2011
• Est. Priority Date: 08/29/2003
• Status: Abandoned Application

• Current Assignee: Life Technologies Corporation (Thermo Fisher Scientific Incorporated)
• Original Assignee: Life Technologies Corporation (Thermo Fisher Scientific Incorporated)
• Inventors: Sharaf, Muhammad A., WOUDENBERG, Timothy M., Bahatt, Dar, Ermakov, Serguei, Connell, Charles R., Hyldig-Nielsen, Jens J., Liu, Timothy Z.
• Application Number:
  US13/030,622
• Publication Number:
  US 20110223596A1
• Time in Patent Office: Days
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 2535/131 Allele specific probes
• CPC Class Codes: C12Q 2563/107 fluorescence
• CPC Class Codes: C12Q 2563/185 Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
• CPC Class Codes: C12Q 2565/1025 labels being on the same oligonucleotide

Abstract

The present invention generally relates to the detection of analytes, particularly biomolecules in samples. The invention also relates to compositions, methods, and kits for detecting the presence of analytes, typically in multiplex detection formats. The invention also relates to methods for determining the presence of at least one analyte in a sample, the methods employing employ single molecule detection techniques to individually detect at least one molecular complex or at least part of a molecular complex.

Claims

1. A method for determining the presence of at least one analyte in a sample, comprising:

a) amplifying at least one analyte to form at least one analyte surrogate,

b) forming at least one molecular complex comprising (a) the at least one analyte, at least one analyte surrogate, or at least one analyte and at least one analyte surrogate and (b) at least one first linear probe comprising at least one reaction portion and at least one identity portion comprising at least one coded molecular tag, wherein the coded molecular tag comprises at least one labeling position comprising a multiplicity of reporter groups in an ordered pattern, wherein the reporter groups within the at least one labeling position are from at least two different reporter group species; and

c) individually detecting the ordered pattern of the multiplicity of reporter groups in the coded molecular tag of the at least one molecular complex or at least part of the at least one molecular complex to determine the presence of the at least one analyte in the sample.

2. The method of claim 1, wherein the molecular complex further comprises at least one second probe comprising at least one reaction portion and at least one analytical portion.

3. The method of claim 1, wherein the at least one identity portion comprises a multiplicity of fluorescent reporter groups.

4. The method of claim 1, wherein the at least one identity portion comprises at least one peptide nucleic acid (PNA), at least one pseudocomplementary peptide nucleic acid (pcPNA), at least one dendrimer, or combinations thereof.

5. The method of claim 1, wherein the at least one identity portion further comprises at least one affinity tag, at least one mobility modifier, or at least one affinity tag and at least one mobility modifier.

6. The method of claim 1, wherein the at least one identity portion is within, coextensive with, or overlaps at least part of the reaction portion of the second probe.

7. The method of claim 1, wherein the at least one analytical portion is within, coextensive with, or overlaps at least part of the reaction portion of the second probe.

8. The method of claim 1, wherein the at least one analytical portion comprises at least one PNA, at least one pcPNA, at least one reporter group, or combinations thereof.

9. The method of claim 1, wherein the at least one analytical portion comprises at least one fluorophore, at least one mobility modifier, at least affinity tag, or combinations thereof.

10. The method of claim 2, wherein at least part of the reaction portion of the at least one first probe and at least part of the reaction portion of the at least one second probe hybridize to complementary sequences on the same strand comprising of the at least one analyte, the at least one analyte surrogate or the at least one analyte and at least one analyte surrogate.

11. The method of claim 10, wherein the at least part of the reaction portion of the at least one first probe and the at least part of the reaction portion of the at least one second probe hybridize adjacent to one another.

17. The method of claim 1, wherein the individually detecting comprises at least one scanning probe microscopy technique, at least one applied optical spectroscopy technique, or both at least one scanning probe microscopy technique and at least one applied optical spectroscopy technique.

18. The method of claim 1, wherein the individually detecting comprises attaching at least one molecular complex or at least part of a molecular complex, tethering at least one molecular complex or at least part of a molecular complex, or both attaching and tethering at least one molecular complex or at least part of a molecular complex directly or indirectly to a substrate and individually detecting the ordered pattern of the multiplicity of reporter group species of the coded molecular tag of the at least one molecular complex or at least part of a molecular complex.

19. The method of claim 1, wherein the ordered pattern of the multiplicity of reporter group species of the coded molecular tag of the at least one molecular complex or at least part of a molecular complex is individually detected in solution.

20. The method of claim 1, wherein the reporter group species is selected from the group consisting of fluorophores, radioisotopes, chromogens, enzymes, antigens, epitope tags, heavy metals, dyes, phosphorescence groups, chemiluminescent groups, electrochemical detection moieties, affinity tags, binding proteins, phosphors, rare earth chelates, near-infrared dyes, and electrochemiluminescent labels.

21. The method of claim 1, wherein the at least one analyte comprises at least one amino acid, at least one carbohydrate subunit, at least one peptide bond, at least one glycosidic bond, at least one fatty acid side chain, at least one alkyl group, at least one allyl group, at least one aryl group, at least one aromatic ring structure, or combinations thereof.

22. The method of claim 2, wherein at least part of the reaction portion of the at least one first probe, at least part of the reaction portion of the at least one second probe, or at least part of the reaction portion of the at least one first probe and part of the reaction portion of the at least one second probe comprise at least one amino acid, at least one ribonucleotide, at least one deoxyribonucleotide, at least one PNA, at least one pcPNA, or combinations thereof.

23. The method of claim 2, further comprising a probe set comprising at least one first probe and at least one second probe, wherein the at least one first probe, at least one second probe or at least one first probe and at least one second probe comprise at least one antibody that reacts specifically with at least one analyte, at least one analyte surrogate, or both.

24. The method of claim 2, further comprising a probe set comprising at least one first probe and at least one second probe, wherein the at least one first probe, at least one second probe or at least one first probe and at least one second probe comprise at least one aptamer that reacts specifically with at least one analyte, at least one analyte surrogate, or both.

25. The method of claim 1, further comprising a probe set comprising at least one first probe and at least one second probe, wherein the at least one first probe, at least one second probe or at least one first probe and at least one second probe comprise at least one binding protein that reacts specifically with at least one analyte, at least one analyte surrogate, or both.

12-16. -16. (canceled)